Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...
Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...
Health and Me on MSN
Ozempic launches in India at Rs 2,200 for starter dose: All you need to know
Novo Nordisk has launched its popular diabetes drug Ozempic in India, with the weekly 0.25 mg starter dose priced at ₹2,200.
Millions of Americans have successfully lost weight with semaglutides, the game-changing class of drugs that includes Ozempic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback